Market Overview

Aortic Stenosis Forecast In 25 Major Markets 2018-2028


Dublin, Aug. 21, 2018 (GLOBE NEWSWIRE) -- The "Aortic Stenosis Forecast In 25 Major Markets 2018-2028" report has been added to's offering.

Aortic Stenosis (AS) is the occlusion or loss of aortic valve surface area resulting in stenosis of the aortic valve. Currently, AS is thought to be the most common form of valvular heart disease in Western countries.

This report provides the current prevalent population for AS across 25 Major Markets (USA, Canada, France, Germany, Italy, Spain, UK, Poland, Netherlands, Norway, Sweden, Denmark, Finland, Iceland, Ireland, Russia, Turkey, Japan, China, South Korea, India, Australia, Brazil, Mexico, Argentina) split by gender and 5-year age cohort. Along with the current prevalence, the report provides an overview of the risk factors, aetiology, disease diagnosis and prognosis along with specific variations by geography and ethnicity.

Providing a value-added level of insight from the analysis team , several of the main symptoms and co-morbidities of AS have been quantified and presented alongside the overall prevalence figures. These sub-populations within the main disease are also included at a country level across the 10-year forecast snapshot.

Main symptoms and co-morbidities for AS include:

  • Previous myocardial infarct / Angina
  • Carotid atherosclerosis
  • COPD
  • Lower limb atherosclerosis
  • Atrial fibrillation
  • Heart failure

Reasons to buy

  • Ability to quantify patient populations in global AS market to target the development of future products, pricing strategies and launch plans.
  • Further insight into the prevalence of the subdivided types of AS and identification of patient segments with high potential.
  • Delivery of more accurate information for clinical trials in study sizing and realistic patient recruitment for various countries.
  • Better understanding on the impact of specific co-morbid conditions on the prevalent population of AS patients.
  • Identification of AS patient sub-populations that require treatment.
  • Better understanding of the specific markets that have the largest number of AS patients.

Key Topics Covered

  1. List Of Tables And Figures
  2. Introduction
  3. Cause Of The Disease
  4. Risk Factors & Prevention
  5. Diagnosis Of The Disease
  6. Variation By Geography/Ethnicity
  7. Disease Prognosis & Clinical Course
  8. Management Of Aortic Valve Stenosis
  9. Key Comorbid Conditions / Features Associated With The Disease
  10. Methodology For Quantification Of Patient Numbers
  11. Additional Data
  12. Top-Line Prevalence For Aortic Stenosis
  13. Features Of Aortic Stenosis Patients
  14. Mild Aortic Stenosis
  15. Moderate Aortic Stenosis
  16. Severe Aortic Stenosis
  17. Symptomatic
  18. Asymptomatic
  19. Comorbidities Of Aortic Stenosis Patients
  20. Moderate Aortic Stenosis
  21. Severe Aortic Stenosis
  22. Symptomatic
  23. Asymptomatic
  24. Abbreviations Used In The Report
  25. Other Publisher Services & Solutions
  26. Reports & Publications
  27. Online Epidemiology Databases
  28. Online Pharmaceutical Pricing Database
  29. References
  30. Appendix

For more information about this report visit

Did you know that we also offer Custom Research? Visit our Custom Research page to learn more and schedule a meeting with our Custom Research Manager.

         Laura Wood, Senior Manager
         For E.S.T Office Hours Call 1-917-300-0470
         For U.S./CAN Toll Free Call 1-800-526-8630
         For GMT Office Hours Call +353-1-416-8900
Related Topics: Cardiovascular Drugs 

Primary Logo

View Comments and Join the Discussion!

Latest Ratings

ADNTRBC CapitalDowngrades16.0
DLPHRBC CapitalDowngrades17.0
MTORRBC CapitalDowngrades19.0
View the Latest Analytics Ratings
Don't Miss Out!
Join Our Newsletter
Subscribe to:
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Fintech Focus
Your weekly roundup of hot topics in the exciting world of fintech.
Thank You
for registering for Benzinga’s newsletters and alerts.
• The Daily Analysts Ratings email will be received daily between 7am and 10am.
• The Market in 5 Minutes email will be received daily between 7am and 8am.
• The Fintech Focus email will be received every Friday between 2pm and 5pm.